NEW YORK, October 6, 2020-- Catalio Capital Management LP (Catalio), a prominent life sciences investment firm, announced today the close of its second venture fund, Catalio Nexus II. The fund was oversubscribed and closed at its hard cap of $100 million, backed by private equity and hedge fund investors, as well as institutional family offices and foundations. In addition to closing its largest fund to date, Catalio announced the opening of a flagship office in Manhattan to facilitate the firm’s rapid growth.